NeuroBo Pharmaceuticals News

Maxim Group Maintains NeuroBo Pharmaceuticals(NRBO.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsAug 15 11:32 ET

Buy Rating for NeuroBo Pharmaceuticals Based on Financial Stability and Promising Developmental Pipeline

TipRanksAug 15 11:07 ET

Maxim Group Maintains NeuroBo Pharmaceuticals(NRBO.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsJul 31 13:31 ET

Buy Rating Affirmed for NeuroBo Pharmaceuticals on Strategic Licensing and Promising Clinical Outcomes

TipRanksJul 31 13:19 ET

Buy Rating Affirmed for NeuroBo Pharmaceuticals on Promising Obesity and MASH Drug Developments

TipRanksMay 17 10:50 ET

Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target

MT NewswiresMay 8 10:36 ET

NeuroBo Pharmaceuticals Analyst Ratings

BenzingaMay 8 10:11 ET

Maxim Group Initiates Coverage On NeuroBo Pharmaceuticals With Buy Rating, Announces Price Target of $10

BenzingaMay 8 10:10 ET

NeuroBo Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsDec 7, 2022 07:52 ET